On 14 November 2011, it was announced that trials into a new drug, alemtuzumab, have been successful - a significant development for those suffering from multiple sclerosis (MS).

The Freemasons' Grand Charity gave £100,000 towards this research in 2010, at the University of Cambridge.

 

For more information see http://www.grandcharity.org/news.php/80/medical_breakthrough_for_multiple_sclerosis